Quantitative Proteomics with siRNA Screening Identifies Novel Mechanisms of Trastuzumab Resistance in HER2 Amplified Breast Cancers

Alaina Boyer, Ron Bose|Molecular & Cellular Proteomics|2012

Cited by 47